Skip to content

Dr. Koen Rappé

Active
Private limited companyfounded 2025active for 1 yearWestkapellestraat 128, 8301 Knokke-Heist, BelgiumKBO/BCE: BE 1026.650.869
Summary

Dr. Koen Rappé has been active since 2025 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €14,802 and a net result of €9,802. Its solvency ranks better than 59% of 20,706 sector peers (NACE 86, financial year 2025). The computed 12-month bankruptcy probability is below 0.1% (very low).

Overview

Official details

Source: KBO
Status
Active since 20-08-2025 Normal situation
Activity
General medical practice NACE 86210
Establishment unit
2.377.405.464 8301 Knokke-Heist, since 20-08-2025
Financial year end
31 December
Peppol
Reachable since 04-09-2025

Board and ownership

Board

Financial position

96 Excellent Checked score 2025
Bankruptcy probabilitywithin 12 months
< 0.1%
Annual accounts 2025
Gross margin
€13,718
Turnover
≈ €86,000
estimated
Profit
€9,802
Equity
€14,802
Total assets
€20,553
Score breakdownlowers riskSector: Human health activities (NACE 86)Liquidity: current ratio 2.50, cash €5,498Figures for financial year 2025 (filed on 23-06-2026)Equity €14,802 (72.0% of total assets)Show the evidence

Checked score

Score 2025
96 / 100
Excellent
Probability in this band: under 0.55%
Financially stronger than 65% of micro companies in human health (NACE 86)
Financial strength
Strong
Solvency 97
equity 72.0% of total assets
Liquidity 72
short-term debt 28.0% · cash 26.8%
Profitability 100
return on assets 47.7%
Bankruptcy probability within 12 months
< 0.1% Very low
0%0.5%1.5%4%10%≥ 25%

Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median < 0.1% (24,160 companies, NACE 86, micro)
Last 24 months 09-2026: < 0.1%highest value 10-2026: < 0.1%● unchanged vs 09-2026highest value 11-2026: < 0.1%● unchanged vs 10-2026highest value
Credit of up to €1,000 on 30-day terms is acceptable
Liquidity is ample, with a current ratio of 2.5, above the usual 1.5. Short-term debt is 28% and cash 26.8% of total assets. 28% of the assets are financed with debt and provisions.
Calculation

The band follows from the bankruptcy probability. 10 more points roughly halve it.

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 86, micro). It does better than 60% of them on solvency, 53% on liquidity and 80% on profitability.

The bankruptcy probability was computed on 02-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Six signals.
lowers riskraises riskneutral
lowers risk · Sector: Human health activities (NACE 86)
KBO
lowers risk · Liquidity: current ratio 2.50, cash €5,498
NBB · annual accounts
lowers risk · Figures for financial year 2025 (filed on 23-06-2026)
NBB · annual accounts
lowers risk · Equity €14,802 (72.0% of total assets)
NBB · annual accounts
raises risk · Young company
Founded in 2025, a year ago. Young companies fail more often than established ones; the risk is highest 2 to 8 years after founding.
KBO · incorporation date
Age against the risk zone
highest failure risk from 2 to 8 years 1 year 0 10 years
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 23-06-2026, 38 days ahead of the deadline.
NBB · 1 filing
Deviation from the deadline
2025
38 days early
← before the deadline after the deadline →
Searched, nothing found (1)
neutral · No strike-offs in the KBO publications
That holds for every publication since incorporation in 2025.
KBO publications

Key points

  • Caution: Less equity than 85% of companies in human healthsector median €124,634 · 20,708 companies €14,802 View

Recent changes

  1. · Gazette deed IncorporationStarting capital €5,000 · Appointment: Dr. Koen Rappé (director)
All 2 events

Comparable companies

These companies have the same main activity as Dr. Koen Rappé: general medical practice (NACE 86210). They are comparable in size and age: total assets between €15,700 and €22,600, founded in 2025.

CompanyTotal assetsGross margin
Dr. Koen Rappé Knokke-Heist€20,553€13,718
HUISARTS Dr. BERNARD BAERT Gent€19,911€13,426
VSBD Chaudfontaine€21,537€12,658
J.S. MEDIC Aarschot€22,605€14,568
MedWens Antwerpen€19,939€15,312
LEORIS Ledegem€17,898€13,294
Dr. Laura Ruymaekers Ardooie€15,746€15,849
Full comparison

Key facts about Dr. Koen Rappé

What is the company number of Dr. Koen Rappé?
The company number of Dr. Koen Rappé is 1026.650.869. The VAT number is the same number with BE in front: BE 1026.650.869.
Where is Dr. Koen Rappé based?
The registered office is at Westkapellestraat 128, 8301 Knokke-Heist.Company details
What does Dr. Koen Rappé do?
According to the KBO register, the main activity is general medical practice (NACE 86210).
What is the legal form of Dr. Koen Rappé?
The legal form of Dr. Koen Rappé is Private limited company (BV).
When was Dr. Koen Rappé founded?
Dr. Koen Rappé was founded on 20-08-2025.
Is Dr. Koen Rappé still active?
Yes, Dr. Koen Rappé is an active enterprise in the KBO register.
What is the turnover of Dr. Koen Rappé?
The turnover in financial year 2025 is ≈ €86,000. This figure is estimated from the gross margin of €13,718 and 48 comparable companies (NACE 86). It probably lies between €59,000 and €140,000. It is a rough estimate.Financials
Is Dr. Koen Rappé profitable?
In financial year 2025, Dr. Koen Rappé made a profit of €9,802.
Where can I find the annual accounts of Dr. Koen Rappé?
Dr. Koen Rappé filed 1 annual account with the National Bank of Belgium, for financial year 2025.

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.